Published January, 2013
By Mark S. Talamonti and Sam G. Pappas
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available

Liver-Directed Therapy for Primary and Metastatic Liver Tumors is a comprehensive examination of tumors of the liver. Because of the unique and comprehensive examination of liver tumors, this work is an excellent resource for surgical, transplant and medical oncologists, surgeons, gastroenterologists, and radiologists.

---

Published December, 2012
By Gary H. Lyman, David C. Dale and Gary Lyman
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available

This volume reviews and integrates the major advances in our understanding of the underlying molecular biology and pharmacology of hematopoietic growth factors in oncology. The results of well designed and executed randomized controlled trials are included.

---

Published December, 2012
By Franco M. Muggia
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available

Taxanes are restructuring treatment regimens in breast cancer, and high-dose strategies are described with peripheral blood progenitor autografting in the treatment of ovarian and breast cancers.

---

Published November, 2012
By Robert F. Ozols
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available

In recent years, there have been major advances in the treatment of patients with gynecologic malignancies. The advances made in the treatment of gynecologic malignancies are due, in part, to the clinical studies performed by many of the contributors to this volume.

---

Published November, 2012
By Teresa K. Woodruff, Laurie Zoloth, Lisa Campo-Engelstein, Sarah Rodriguez and Teresa Woodruff
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available

Oncofertility has emerged as a way to address potential lost or impaired fertility in cancer patients and survivors, with active biomedical research that is developing new ways to help these individuals preserve their ability to have biological children.

---

Published November, 2012
By Joseph A. Sparano
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available

Infection with the human immunodeficiency virus (HIV) and human T-cell lymphotropic virus type I (HTLV-I) is known to be associated with an increased risk of neoplastic disorders, especially Kaposi's sarcoma and aggressive B-cell lymphoma for the former, and T-cell lymphoma for the latter.

---

Published November, 2012
By I. Craig Henderson
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available

The results of randomized trials evaluating the use of early or adjuvant systemic treatment for patients with resectable breast cancer provide an eloquent rebuttal to those who would argue that we have made no progress in the treatment of cancer.

---

Published November, 2012
By Robert F. Ozols
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available

The importance of drug resistance in cancer chemotherapy cannot be over stated. Drug Resistance in Chemotherapy the results of comprehensive laboratory studies aimed at understanding the mechanisms for resistance to individual agents and to the development of broad cross-resistance were described.

---

Published November, 2012
By Robert A. Figlin
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available

Kidney cancer is a heterogenous disease. This book will be useful to the specialist (oncologist and urologist), primary care physicians, patients and family members dealing with kidney cancer.

---

Published October, 2012
By Asad Bashey and Edward D. Ball
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available

Non-myeloablative allogeneic stem cell transplantation (also known as mini-transplantation or reduced-intensity conditioning transplantation) is a major advance in the field of hematopoietic transplantation within the last 5 years.

---